Entering text into the input field will update the search result below

Inozyme Pharma appoints Sanjay Subramanian as CFO

Mar. 08, 2022 7:53 AM ETInozyme Pharma, Inc. (INZY)By: Preeti Singh, SA News Editor
  • Inozyme Pharma (NASDAQ:INZY) has announced two executive appointments, with Sanjay Subramanian joining the team as CFO and Soojin Kim as SVP and Chief Technical Operations Officer (CTOO).
  • Mr. Subramanian has over 20 years of corporate finance, capital markets, and business development expertise, having recently

Recommended For You


Have a tip? Submit confidentially to our News team. Found a factual error? Report here.

About INZY

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

Related Stocks

SymbolLast Price% Chg
Inozyme Pharma, Inc.
Immuneering Corporation
Immutep Limited
Reneo Pharmaceuticals, Inc.
Fennec Pharmaceuticals Inc.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.